Trust Bio-sonics’ Lipid Microsphere Platform: Paving New Paths to Overcome Hard-to-Treat Cancers

Date: 2025/ 7/ 17 Thu., Media: Global Bio & Investment

News Link：

(Trust Bio-sonics' Lipid Microsphere Platform: Paving New Paths to Overcome Hard-to-Treat Cancers)

Trust Bio-sonics is a forward-thinking biotech company specializing in the applications of lipid microsphere technology. The company focuses on the cutting-edge fields of ultrasound enhancers and Ultrasound-Mediated Drug Delivery (UMDD). By integrating its proprietary micro/nanobubble platform with focused ultrasound, Trust Bio-sonics has developed a high-precision, non-invasive therapeutic drug delivery platform. Guided by real-time imaging, this technology significantly enhances drug penetration and targeting selectivity while minimizing systemic side effects.

Currently, the company's product pipeline targets cardiovascular imaging and oncology. Its flagship product—a novel cardiac ultrasound contrast agent—has already advanced to Phase III clinical trials. Furthermore, the company's UMDD strategy for treating pancreatic cancer and liver metastases has received Phase I clinical trial approval, demonstrating the transformative potential of precision drug delivery in the fight against refractory malignant tumors.

- Check the news link for full details -